|
Basic information |
| Metabolite name | 5,7-dihydroxy-2-(1-hydroxy-3,5-dimethoxy-4-oxocyclohex-2-en-1-yl)-4H-chromen-4-one |
 | N/A |
 |
N/A |
 |
131834559 |
| Synonyms | NA |
| No. of studies | 2 |
|
Relationship between 5,7-dihydroxy-2-(1-hydroxy-3,5-dimethoxy-4-oxocyclohex-2-en-1-yl)-4H-chromen-4-one and depression (count: 2) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1135 | Type1 | PSD group vs. control group | Faece | Sprague-Dawley rat | Down |
| Study M949 | Type1 | ovariectomy group vs. control group | Serum | ICR mouse | Up |
| Study M949 | Type2 | ovariectomy + high dose of Ginseng total saponins and Fuzi total alkaloids group vs. ovariectomy group | Serum | ICR mouse | Down |
| Study M949 | Type2 | ovariectomy + middle dose of Ginseng total saponins and Fuzi total alkaloids group vs. ovariectomy group | Serum | ICR mouse | Down |
| Study M949 | Type2 | ovariectomy + low dose of Ginseng total saponins and Fuzi total alkaloids group vs. ovariectomy group | Serum | ICR mouse | Down |
| Study M949 | Type2 | ovariectomy + fluoxetine group vs. ovariectomy group | Serum | ICR mouse | Down |